Blog

RSS Feed
Posted by Michael Wonder on 01 Aug 2019

Proposal to enhance the transparency of CADTH’s review reports and recommendations

31 July 2019 - CADTH is committed to increasing the transparency of its health technology assessment processes.  ...

Read more →
Posted by Michael Wonder on 27 May 2019

'You disappointed us': Why is Canada opposing more transparency in drug prices?

25 May 2019 - Pharma industry says high prices are necessary to cover costs. Some nations want to see the data. ...

Read more →
Posted by Michael Wonder on 18 Mar 2018

Costco under investigation by Ontario forensic team over drug company payments

16 March 2018 - Rebates not allowed in province in bid to drive down overall price of generics. ...

Read more →
Posted by Michael Wonder on 30 Sep 2017

Blacked-out information reveals secret world of drug prices

30 September 2017 - This week, the Patented Medicine Prices Review Board ruled the Canadian price of the drug Soliris is ...

Read more →
Posted by Michael Wonder on 01 Mar 2016

CADTH to provide drug plans with copies of CDR submission or resubmission materials

25 February 2016 - CADTH has begun providing authorized recipients from the CDR-participating drug plans with copies of all category 1 ...

Read more →
Posted by Michael Wonder on 26 Feb 2016

Update on procedures for the CADTH Common Drug Review and pan-Canadian Oncology Drug Review: mandatory disclosure of a submitted drug price

25 February 2016 - In late September 2015, CADTH invited stakeholder comments and feedback on proposed revisions to the CADTH Common ...

Read more →